by Tyler Durden
Authored by Zachary Stieber via The Epoch Times,
The top U.S. public health agency labeled multiple news articles as misinformation even though the articles were accurate, according to internal emails and experts.
The U.S. Centers for Disease Control and Prevention (CDC) added the misinformation labels to articles from The Epoch Times in widely-circulated internal messages, according to copies obtained by The Epoch Times.
One of the articles reported on a peer-reviewed paper that found heart inflammation, or myocarditis, was more common after COVID-19 vaccination than after COVID-19 infection.
Nordic researchers reviewed electronic health records and counted 109 cases of myocarditis following COVID-19 infection compared to 530 after vaccination. Their study was published by the British Medical Journal.
An internal CDC email said that the study “has been picked up by anti-vax proponents as evidence that vax was more likely to cause myocarditis than COVID-19 infection,” and provided a hyperlink to The Epoch Times article.
The Feb. 7, 2023, email listed the article under “points of confusion/potential rumors/misinformation.”
The CDC did not list any data or other information supporting its label.
“The Epoch Times article should not be labeled as misinformation,” Dr. Tracy Hoeg, a physician-scientist at the University of California-San Francisco, told The Epoch Times via email.
Dr. Hoeg said the Nordic study aligned with earlier research, including a paper published by JAMA Cardiology that found myocarditis rates were higher among some populations after vaccination compared to after infection.
Another CDC email claimed a story reporting on how the U.S. government was receiving royalty payments from Moderna’s COVID-19 vaccine was inaccurate or misleading.
The Epoch Times article reported on how Moderna officials disclosed in an earnings call that the company entered a patent agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), sent a payment of $400 million, and would be paying additional royalties in the future.
“Anti-vax proponents question Moderna’s new patent agreement with NIAID, citing catch up payments and royalties as a ‘conflict of interest,” the CDC email, dated March 1, 2023, stated.
